Fri 27 Nov 2009 | 15:50 EST
You are here: Home > Business & Finance > Stocks > Company News
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Company News for Genzyme Corporation

Genzyme Corporation (GENZ.O) (Nasdaq)
sector: Healthcare . industry: Biotechnology ยท View GENZ on other exchanges
As of  1:00pm EST
51.07USD
Price Change
-0.45
Percent Change
-0.87%
 
Research Another Stock: Symbol Look-up

Friday, 27 Nov 2009

UPDATE 1-Genzyme CEO sells 200,000 of company's shares
Wednesday, 25 Nov 2009 12:44pm EST 
UPDATE 1-Shire asks EU for Gaucher drug approval
Tuesday, 24 Nov 2009 07:48am EST 
UPDATE 2-Genzyme negative news continues; stops drug trial
Wednesday, 18 Nov 2009 09:39am EST 
UPDATE 2-Isis drug meets all study goals; filing delayed
Tuesday, 17 Nov 2009 11:28am EST 
Isis cholesterol drug meets all goals of key trial
Tuesday, 17 Nov 2009 09:32am EST 
Isis cholesterol drug meets all goals of key trial
Tuesday, 17 Nov 2009 09:30am EST 
UPDATE 1-Genzyme says FDA declines to approve Pompe disease drug
Monday, 16 Nov 2009 11:07am EST 
UPDATE 4-Steel, rubber found in some Genzyme drugs
Friday, 13 Nov 2009 06:54pm EST 
Genzyme shares tumble after FDA statement
Friday, 13 Nov 2009 12:17pm EST 
Genzyme shares tumble after FDA statement
Friday, 13 Nov 2009 12:15pm EST 

Analyst Research

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.